Andressa Laino

发表

Decreased Suppression and Increased Phosphorylated STAT3 in Regulatory T Cells are Associated with Benefit from Adjuvant PD-1 Blockade in Resected Metastatic Melanoma

David M. Woods, A. Laino, D. Woods, 2018, Clinical Cancer Research.

Targeting Histone Deacetylases in Melanoma and T-cells to Improve Cancer Immunotherapy

A. Laino, Andressa Laino, 2016 .

HDAC6 selective inhibition of melanoma patient T-cells augments anti-tumor characteristics

David M. Woods, I. Dolgalev, A. Laino, 2019, Journal of Immunotherapy for Cancer.

Rapid Expansion of Highly Functional Antigen-Specific T Cells from Patients with Melanoma by Nanoscale Artificial Antigen-Presenting Cells

David M. Woods, A. Laino, D. Woods, 2020, Clinical Cancer Research.

C reactive protein impairs adaptive immunity in immune cells of patients with melanoma

David M. Woods, A. Laino, D. Woods, 2020, Journal for ImmunoTherapy of Cancer.

Clinical and immune correlate results from a phase 1b study of the histone deacetylase inhibitor mocetinostat with ipilimumab and nivolumab in unresectable stage III/IV melanoma

David M. Woods, A. Laino, D. Woods, 2022, Melanoma research.

Serum interleukin-6 and C-reactive protein are associated with survival in melanoma patients receiving immune checkpoint inhibition

David M. Woods, A. Laino, D. Woods, 2020, Journal for immunotherapy of cancer.

767 Safety and preliminary efficacy of mRNA-2752, a lipid nanoparticle encapsulating mRNAs encoding human OX40L/IL-23/IL-36γ for intratumoral (ITu) injection, and durvalumab (IV) in TNBC, HNSCC, and melanoma

A. Jimeno, J. Frederick, S. Kummar, 2022, Regular and Young Investigator Award Abstracts.

Nivolumab and ipilimumab are associated with distinct immune landscape changes and response-associated immunophenotypes.

David M. Woods, Santi S. Adavani, P. Chattopadhyay, 2020, JCI insight.